- Home
- JXG vs BDRX Comparison
JXG vs BDRX Comparison
Compare JXG & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXG
- BDRX
- Stock Information
- Founded
- JXG N/A
- BDRX 2000
- Country
- JXG China
- BDRX United Kingdom
- Employees
- JXG N/A
- BDRX N/A
- Industry
- JXG
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- JXG
- BDRX Health Care
- Exchange
- JXG Nasdaq
- BDRX Nasdaq
- Market Cap
- JXG 4.7M
- BDRX 3.8M
- IPO Year
- JXG N/A
- BDRX N/A
- Fundamental
- Price
- JXG $0.94
- BDRX $5.39
- Analyst Decision
- JXG
- BDRX
- Analyst Count
- JXG 0
- BDRX 0
- Target Price
- JXG N/A
- BDRX N/A
- AVG Volume (30 Days)
- JXG 118.3K
- BDRX 22.8K
- Earning Date
- JXG 05-15-2025
- BDRX 09-29-2025
- Dividend Yield
- JXG N/A
- BDRX N/A
- EPS Growth
- JXG N/A
- BDRX N/A
- EPS
- JXG 0.86
- BDRX N/A
- Revenue
- JXG $49,840,288.00
- BDRX N/A
- Revenue This Year
- JXG N/A
- BDRX N/A
- Revenue Next Year
- JXG N/A
- BDRX N/A
- P/E Ratio
- JXG $1.06
- BDRX N/A
- Revenue Growth
- JXG 56.53
- BDRX N/A
- 52 Week Low
- JXG $0.55
- BDRX $5.29
- 52 Week High
- JXG $8.40
- BDRX $112.85
- Technical
- Relative Strength Index (RSI)
- JXG 37.93
- BDRX 31.33
- Support Level
- JXG $0.85
- BDRX $5.29
- Resistance Level
- JXG $1.04
- BDRX $5.96
- Average True Range (ATR)
- JXG 0.08
- BDRX 0.50
- MACD
- JXG 0.01
- BDRX 0.01
- Stochastic Oscillator
- JXG 39.33
- BDRX 17.76
About JXG JX Luxventure Limited Common Stock
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.